SCOPUS 정보 검색 플랫폼

Volumn 2, Issue 4, 2001, Pages 214-219

High-dose idarubicin and busulphan as conditioning for autologous stem cell transplantation in acute myeloid leukemia: A feasibility study

(10) Ferrara, F a Annunziata, M a Schiavone, E M a Copia, C a De Simone, M a Pollio, F a Palmieri, S a Viola, A a Russo, C a Mele, G a

a CARDARELLI HOSPITAL (Italy)

Author keywords

Acute myeloid leukemia; Conditioning; Idarubicin; Stem cell transplantation

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BUSULFAN; CD34 ANTIGEN; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; MITOXANTRONE; NORFLOXACIN; PHENYTOIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; AUTOTRANSPLANTATION; BLOOD TRANSFUSION; CANCER RECURRENCE; CELL COUNT; CHROMOSOME INVERSION; CHROMOSOME INVERSION 16; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CLINICAL ARTICLE; CLINICAL TRIAL; CONDITIONING; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION; MALE; MORTALITY; MUCOSA INFLAMMATION; NEUTROPHIL; PARENTERAL NUTRITION; PERIPHERAL BLOOD STEM CELL; THROMBOCYTE;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BUSULFAN; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IDARUBICIN; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; REMISSION INDUCTION; STROKE VOLUME; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 17944366420 PISSN: 14664860 EISSN: None Source Type: Journal
DOI: 10.1038/sj.thj.6200122 Document Type: Article

Times cited : (11)

References (35)

1
- 0032480930
- Chemotherapy compared with autologous and allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first complete remission
- (1998) New England Journal of Medicine , vol.39 , pp. 1649
- Cassileth, P.A.¹ Harrington, D.P.² Appelbaum, F.R.³ Lazarus, H.M.⁴ Rowe, J.M.⁵ Paietta, E.⁶ Willman, C.⁷ Hurd, D.D.⁸ Bennett, J.M.⁹ Blume, K.G.¹⁰ Head, D.R.¹¹ Wiernik, P.H.¹²

2
- 0028889993
- Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myeloid leukemia
- European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano per le Malattie Ematologiche Neoplastiche dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
- (1995) New England Journal of Medicine , vol.332 , pp. 217
- Zittoun, R.A.¹ Mandelli, F.² Willenze, R.³ de Witte, T.⁴ Labar, B.⁵ Resegotti, L.⁶ Leoni, F.⁷ Damasio, E.⁸ Visani, G.⁹ Papa, G.¹⁰ Caronia, F.¹¹ Hayat, M.¹² Stryckmans, P.¹³ Rotoli, B.¹⁴ Leoni, P.¹⁵ Peetermans, M.E.¹⁶ Dardenne, M.¹⁷ Vegna, M.L.¹⁸ Petti, M.C.¹⁹ Solbu, G.²⁰ Sociu, S.²¹ more..

3
- 0032492441
- Randomized comparison of addition of autologous bone marrow transplantation to intensive chemotherapy for acute myeloid leukemia in first remission: Results of MRC AML 10 trial
- (1998) Lancet , vol.351 , pp. 700
- Burnett, A.K.¹ Goldstone, A.H.² Stevens, R.M.F.³ Hann, I.M.⁴ Gray, R.G.⁵ Rees, J.K.H.⁶ Wheatley, K.W.⁷

4
- 0032529505
- Autologous stem cell transplantation in acute myelocytic leukemia
- (1998) Blood , vol.92 , pp. 1073
- Gorin, N.C.¹

5
- 0030763392
- Transplantation of autologous peripheral blood progenitor cells procured after high-dose cytarabine based consolidation chemotherapy for adults with acute myelogenous leukemia in first remission
- (1997) Leukemia , vol.11 , pp. 1533
- Schiller, G.¹ Lee, M.² Miller, T.³ Lill, M.⁴ Mittal Henkle, A.⁵ Paquette, R.⁶ Sawiers, C.⁷ Territo, M.⁸

6
- 9444289886
- In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission
- (1996) Journal of Clinical Oncology , vol.14 , pp. 2206
- Stein, A.S.¹ O'Donnell, M.R.² Chai, A.³ Schmidt, G.M.⁴ Nadenamee, A.⁵ Parker, P.M.⁶ Smith, E.P.⁷ Snyder, D.S.⁸ Molina, A.⁹ Stepan, D.E.¹⁰ Spielberger, R.¹¹ Somlo, G.¹² Margolin, K.A.¹³ Vora, N.¹⁴ Lipsett, J.¹⁵ Lee, J.¹⁶ Niland, J.¹⁷ Forman, S.J.¹⁸

7
- 0028073124
- One hundred twenty five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide. A 10 year single institution experience
- (1994) Blood , vol.84 , pp. 3810
- Laporte, J.P.¹ Douay, L.² Lopez, M.³ Labopin, M.⁴ Jouet, J.P.⁵ Lesage, S.⁶ Stachowiak, J.⁷ Fouillard, L.⁸ Isnard, F.⁹ Noel-Walter, M.P.¹⁰ Pene, F.¹¹ Deloux, J.¹² Van Den Akker, J.¹³ Grande, M.¹⁴ Bauters, F.¹⁵ Najman, A.¹⁶ Gorin, N.C.¹⁷

8
- 0028274055
- Improved outcome for high risk acute myeloid leukemia patients using autologous bone marrow transplantation and monoclonal antibody-purged bone marrow
- (1994) Blood , vol.83 , pp. 1698
- Selvaggi, K.J.¹ Wilson, J.W.² Mills, L.E.³ Corwell, G.G.⁴ Hurd, D.⁵ Dodge, W.⁶ Gingrich, R.⁷ Martin, S.E.⁸ McMillan, R.⁹ Miller, W.¹⁰ Ball, E.D.¹¹

9
- 0031740032
- Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycylophosphamide-purged bone marrow and the busulfan-etoposide preparative regimen: A follow-up report
- (1998) Bone Marrow Transplantation , vol.22 , pp. 865
- Linker, C.A.¹ Ries, C.A.² Damon, L.E.³ Rugo, H.S.⁴ Wolf, J.L.⁵

10
- 0029803832
- BAVC regimen and autograft for acute myelogenous leucemia in second complete remission
- (1996) Bone Marrow Transplantation , vol.18 , pp. 693
- Meloni, G.¹ Vignetti, M.² Avvisati, G.³ Capria, S.⁴ Micozzi, A.⁵ Giona, F.⁶ Mandelli, F.⁷

11
- 0027529871
- Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as preparative regimen
- (1993) Blood , vol.81 , pp. 311
- Linker, C.A.¹ Ries, C.A.² Damon, L.E.³ Rugo, H.S.⁴ Wolf, J.L.⁵

12
- 0032832815
- Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free-survival compared with bone marrow cells
- (1999) Bone Marrow Transplantation , vol.24 , pp. 467
- Visani, G.¹ Lemoli, R.M.² Tosi, P.³ Martinelli, G.⁴ Testoni, N.⁵ Ricci, P.⁶ Motta, M.R.⁷ Gherlinzoni, F.⁸ Leopardi, G.⁹ Pastano, R.¹⁰ Rizzi, S.¹¹ Piccaluga, P.P.¹² Isidori, A.¹³ Tura, S.¹⁴

13
- 0034079833
- Autologous blood cell vs marrow transplantation for acute myeloid leukemia in complete remission: An EBMT retrospective analysis
- (2000) Bone Marrow Transplantation , vol.25 , pp. 1115
- Reiffers, J.¹ Labopin, M.² Sanz, M.³ Korbling, M.⁴ Blaise, D.⁵ De La Rubia, J.⁶ Gorin, N.C.⁷

14
- 0028060210
- Understanding the mechanism of cure of acute myeloid leukemia by allogeneic bone marrow transplantation: Toward the application of interleukin-2 in autologous bone marrow transplantation
- (1994) Journal of Hematotherapy , vol.3 , pp. 47
- Prentice, H.G.¹ Macdonald, I.D.² Hamon, M.D.³

15
- 0026785940
- Autologous bone marrow transplantation followed by interleukin-2 in children with advanced leukemia: A pilot study
- (1992) Leukemia , vol.6 , pp. 780
- Meloni, G.¹ Foa, R.² Tosti, S.³ Vignetti, M.⁴ Mancini, F.⁵ Guarini, A.⁶ Marchis, D.⁷ Gavosto, F.⁸ Mandelli, F.⁹

16
- 0026720403
- Induction of cutaneous graft-versus-host-disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia
- (1992) Blood , vol.79 , pp. 3031
- Yeager, A.M.¹ Vogelsang, G.B.² Jones, R.J.³ Farmer, E.R.⁴ Altomonte, V.⁵ Hess, A.D.⁶ Santos, G.W.⁷

17
- 0021035301
- Marrow transplantation for acute non lymphocytic leukemia after treatment with busulfan and cyclophosphamide
- (1983) New England Journal of Medicine , vol.309 , pp. 1347
- Santos, G.W.¹ Tutschka, P.J.² Brookmeyer, R.³ Saral, R.⁴ Beschorner, W.E.⁵ Bias, W.B.⁶ Braine, H.G.⁷ Burns, W.H.⁸ Elfenbein, G.J.⁹ Kaizer, H.¹⁰

18
- 0023574955
- Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen
- (1987) Blood , vol.70 , pp. 1382
- Tutschka, P.J.¹ Copelan, E.A.² Klein, J.P.³

19
- 0032754440
- Use of idarubicin in pre-transplant conditioning in children with high-risk acute leukemia
- (1999) Bone Marrow Transplantation , vol.24 , pp. 953
- Lawson, S.E.¹ Williams, M.D.² Darbyshire, P.J.³

20
- 0030967802
- Outcome of transplantation for standard-risk leukaemia with graft-depleted of lymphocytes after conditioning with an intensified regimen
- (1997) British Journal of Haematology , vol.98 , pp. 750
- Schaap, N.¹ Schattemberg, A.² Bar, B.³ Preijers, F.⁴ Geurts van Kessel, A.⁵ van der Maazen, R.⁶ de Boo, T.⁷ de Witte, T.⁸

21
- 17744399698
- Idarubicin intensified BUCY2 regimen in allogeneic unmanipulated transplant for high-risk hematological malignancies
- (2000) Leukemia , vol.14 , pp. 2052
- Mengarelli, A.¹ Iori, A.P.² Guglielmi, C.³ Perrone, M.P.⁴ Gozzer, M.⁵ Girmania, C.⁶ Cimino, G.⁷ Testi, A.M.⁸ Ricci, R.⁹ De Felice, L.¹⁰ Girelli, G.¹¹ Mandelli, F.¹² Areese, W.¹³

22
- 0031822004
- Idarubicin to intensify the conditioning regimens of autologous bone marrow transplantation for patients with acute myeloid leukemia in first complete remission
- (1998) Bone Marrow Transplantation , vol.22 , pp. 13
- Jerjis, Sh.¹ Roovers, E.² Muus, P.³ Schap, N.⁴ De Witte, T.⁵

23
- 0000553857
- Proposed revised criteria for the classification of acute myeloid leukemia
- (1985) Annals of Internal Medicine , vol.105 , pp. 626
- Bennett, J.M.¹ Catovski, D.² Daniel, M.T.³ Flandrin, G.⁴ Galton, D.A.G.⁵ Gralnick, H.R.⁶ Sultan, C.⁷

24
- 0034061846
- CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous All-trans-Retinoic acid and chemotherapy
- (2000) Journal of Clinical Oncology , vol.18 , pp. 1295
- Ferrara, F.¹ Morabito, F.² Martino, B.³ Specchia, G.⁴ Liso, V.⁵ Nobile, F.⁶ Boccuni, P.⁷ Di Noto, R.⁸ Pane, F.⁹ Annunziata, M.¹⁰ Schiavone, E.M.¹¹ De Simone, M.¹² Guglielmi, C.¹³ Del Vecchio, L.¹⁴ Lo Coco, F.¹⁵

25
- 0029114759
- Simultaneous occurrence of tetrasomy 21 and trisomy 8 in a patient with early blastic metamorphosis of chronic myeloproliferative disorder
- (1995) American Journal of Hematology , vol.50 , pp. 49
- Sebastio, L.¹ Ferrara, F.² Vicari, L.³ Di Noto, R.⁴ Del Vecchio, L.⁵ Pane, F.⁶ Fasanaro, A.⁷ Cimino, R.⁸ Salvatore, F.⁹ Ventruto, V.¹⁰

26
- 0023711896
- Cytogenetic pattern in acute myelogenous leukemia: A major reproducible determinant of outcome
- (1988) Leukemia , vol.2 , pp. 403-412
- Keating, M.J.¹ Smith, T.L.² Kantarjian, H.³ Cork, A.⁴ Walters, R.⁵ Trujillo, J.M.⁶ McCredie, K.B.⁷ Gehan, E.A.⁸ Freireich, E.J.⁹

27
- 0031835792
- Fludarabine, cytarabine and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia
- (1998) American Journal of Hematology , vol.58 , pp. 105
- Montillo, M.¹ Mirto, S.² Petti, M.C.³ Latagliata, R.⁴ Magrin, S.⁵ Pinto, A.⁶ Zagonel, V.⁷ Mele, G.⁸ Tedeschi, A.⁹ Ferrara, F.¹⁰

28
- 33845382806
- Non parametric estimation from incomplete observations
- (1958) Journal of the American Statistical Association , vol.53 , pp. 457
- Kaplan, E.L.¹ Meier, P.²

29
- 0004221185
- World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. World Health Organization, Geneva
- (1979) , vol.38

30
- 9244253691
- A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75
- (1996) Leukemia , vol.10 , pp. 389
- Reiffers, J.¹ Huguet, F.² Stoppa, A.M.³ Molina, L.⁴ Marit, G.⁵ Attal, M.⁶ Gastaut, J.A.⁷ Michallet, M.⁸ Lepeu, G.⁹ Broustet, A.¹⁰ Pris, J.¹¹ Maraninchi, D.¹² Hollard, D.¹³ Faberes, C.¹⁴ Mercier, M.¹⁵ Hurteloup, P.¹⁶ Danel, P.¹⁷ Tellier, Z.¹⁸ Berthaud, P.¹⁹

31
- 0026586008
- Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia
- (1992) Blood , vol.79 , pp. 313
- Wiernik, P.H.¹ Banks, P.L.² Case D.C., Jr.³ Arlin, Z.A.⁴ Periman, P.O.⁵ Todd, M.B.⁶ Ritch, P.S.⁷ Enck, R.E.⁸ Weitberg, A.B.⁹

32
- 0026650021
- A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: A Southeastern Cancer Study Group Study
- (1992) Journal of Clinical Oncology , vol.10 , pp. 1103
- Vogler, W.R.¹ Velez Garcia, E.² Weiner, R.S.³ Flaum, M.A.⁴ Bartolucci, A.A.⁵ Omura, G.A.⁶ Gerber, M.C.⁷ Banks, P.L.⁸

33
- 0033677352
- High-dose idarubicine, busulphan and melphalan as conditioning for autologous blood stem cell transplantation in multiple myeloma. A feasibility study
- (2000) Bone Marrow Transplantation , vol.26 , pp. 1045
- Meloni, G.¹ Capria, S.² Trasarti, S.³ Ferrazza, G.⁴ Micozzi, A.⁵ Petrucci, M.T.⁶ Simone, F.⁷ Trisolini, S.M.⁸ Mandelli, F.⁹

34
- 0031456102
- Idarubicin, melphalan and cyclophosphamide: An intensified high-dose regimen for the treatment of myeloma patients
- (1997) Leukemia , vol.11 , Issue.SUPPL. 5
- Heyll, A.¹ Sohngen, D.² Kobbe, G.³ Schneider, P.⁴ Bauser, U.⁵ Thiele, K.P.⁶ Wehmeier, A.⁷ Sudhoff, T.⁸ Quenzel, E.M.⁹ Rieth, C.¹⁰ Wernet, P.¹¹ Fischer, J.¹² Frick, M.¹³ Aul, C.¹⁴

35
- 4243595228
- High dose ARA-C as consolidation therapy for patients with core binding factor acute myeloid leukemia
- (2000) Blood , vol.96 , Issue.SUPPL. 1
- Ferrara, F.¹ Copia, C.² Palmieri, S.³ Annunziata, M.⁴ Pollio, F.⁵ Mele, G.⁶ Schiavone, E.M.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.